MASP1 and systemic lupus erythematosus: Further, the observation that active SLE patients demonstrated significantly reduced MASP-1 levels in comparison to inactive SLE patients suggests their consumption during the disease course, similar to complement consumption, thereby supporting their potential role in SLE pathogenesis.